Teleflex/$TFX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Teleflex
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2024 sales), interventional (19%), anesthesia (13%), surgical (15%), interventional urology (11%), original-equipment manufacturing (11%), and other (7%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.
Ticker
$TFX
Sector
Primary listing
NYSE
Industry
Health Care Equipment & Supplies
Headquarters
Employees
14,100
ISIN
US8793691069
Website
Teleflex Metrics
BasicAdvanced
$5.3B
37.18
$3.20
1.08
$1.36
1.14%
Price and volume
Market cap
$5.3B
Beta
1.08
52-week high
$245.46
52-week low
$115.94
Average daily volume
515K
Dividend rate
$1.36
Financial strength
Current ratio
2.277
Quick ratio
1.121
Long term debt to equity
46.723
Total debt to equity
48.96
Dividend payout ratio (TTM)
41.99%
Interest coverage (TTM)
7.14%
Profitability
EBITDA (TTM)
842.418
Gross margin (TTM)
55.98%
Net profit margin (TTM)
4.96%
Operating margin (TTM)
18.84%
Effective tax rate (TTM)
28.88%
Revenue per employee (TTM)
$210,000
Management effectiveness
Return on assets (TTM)
4.84%
Return on equity (TTM)
3.48%
Valuation
Price to earnings (TTM)
37.182
Price to revenue (TTM)
1.838
Price to book
1.3
Price to tangible book (TTM)
-6.79
Price to free cash flow (TTM)
11.529
Free cash flow yield (TTM)
8.67%
Free cash flow per share (TTM)
1,031.57%
Dividend yield (TTM)
1.14%
Forward dividend yield
1.14%
Growth
Revenue change (TTM)
0.29%
Earnings per share change (TTM)
-48.69%
3-year revenue growth (CAGR)
2.23%
10-year revenue growth (CAGR)
5.16%
3-year earnings per share growth (CAGR)
-32.24%
10-year earnings per share growth (CAGR)
-2.41%
What the Analysts think about Teleflex
Analyst ratings (Buy, Hold, Sell) for Teleflex stock.
Teleflex Financial Performance
Revenues and expenses
Teleflex Earnings Performance
Company profitability
Teleflex News
AllArticlesVideos
Teleflex Completes Acquisition of BIOTRONIK's Vascular Intervention Business
GlobeNewsWire·1 week ago
New Prospective Cohort Study Reporting the Efficacy of Arrow™ Chlorhexidine-Impregnated Central Venous Catheters Demonstrates Reduced Infection Rates Among ICU Patients
GlobeNewsWire·4 weeks ago
Teleflex Highlights Prostate Health and Quality-of-Life Awareness Through Two Key Public Initiatives During Men's Health Month
GlobeNewsWire·4 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Teleflex stock?
Teleflex (TFX) has a market cap of $5.3B as of July 11, 2025.
What is the P/E ratio for Teleflex stock?
The price to earnings (P/E) ratio for Teleflex (TFX) stock is 37.18 as of July 11, 2025.
Does Teleflex stock pay dividends?
Yes, the Teleflex (TFX) stock pays dividends to shareholders. As of July 11, 2025, the dividend rate is $1.36 and the yield is 1.14%. Teleflex has a payout ratio of 41.99% on a trailing twelve-month basis.
When is the next Teleflex dividend payment date?
The next Teleflex (TFX) dividend payment date is unconfirmed.
What is the beta indicator for Teleflex?
Teleflex (TFX) has a beta rating of 1.08. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.